STAT3 and prostate carcinoma: HR prostate cancer (LNCaP-HR and TRAMP-HR) had higher levels of IL-6, more activated STAT3 and AR compared to hormone sensitive prostate cancer cells (LNCaP and TRAMP-C1) shown in our previous and the present study [19].